QS Investors’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | $442K | Hold |
36,900
| – | – | 0.01% | 791 |
|
2021
Q1 | $463K | Sell |
36,900
-700
| -2% | -$8.78K | 0.01% | 831 |
|
2020
Q4 | $587K | Buy |
37,600
+11,292
| +43% | +$176K | 0.01% | 706 |
|
2020
Q3 | $249K | Sell |
26,308
-98,281
| -79% | -$930K | ﹤0.01% | 997 |
|
2020
Q2 | $1.12M | Hold |
124,589
| – | – | 0.02% | 691 |
|
2020
Q1 | $794K | Hold |
124,589
| – | – | 0.01% | 730 |
|
2019
Q4 | $1.02M | Sell |
124,589
-2,750
| -2% | -$22.6K | 0.01% | 774 |
|
2019
Q3 | $1.15M | Hold |
127,339
| – | – | 0.01% | 739 |
|
2019
Q2 | $1.37M | Sell |
127,339
-3,574
| -3% | -$38.5K | 0.01% | 709 |
|
2019
Q1 | $1.25M | Sell |
130,913
-734
| -0.6% | -$7K | 0.01% | 754 |
|
2018
Q4 | $1.51M | Hold |
131,647
| – | – | 0.02% | 657 |
|
2018
Q3 | $2.23M | Hold |
131,647
| – | – | 0.02% | 589 |
|
2018
Q2 | $1.87M | Buy |
131,647
+12
| +0% | +$170 | 0.02% | 623 |
|
2018
Q1 | $2.5M | Sell |
131,635
-9,786
| -7% | -$186K | 0.03% | 501 |
|
2017
Q4 | $2.32M | Sell |
141,421
-594
| -0.4% | -$9.74K | 0.02% | 558 |
|
2017
Q3 | $2.13M | Sell |
142,015
-3,221
| -2% | -$48.3K | 0.02% | 588 |
|
2017
Q2 | $1.28M | Hold |
145,236
| – | – | 0.01% | 708 |
|
2017
Q1 | $755K | Hold |
145,236
| – | – | 0.01% | 861 |
|
2016
Q4 | $443K | Hold |
145,236
| – | – | ﹤0.01% | 910 |
|
2016
Q3 | $672K | Hold |
145,236
| – | – | 0.01% | 831 |
|
2016
Q2 | $841K | Hold |
145,236
| – | – | 0.01% | 804 |
|
2016
Q1 | $879K | Hold |
145,236
| – | – | 0.01% | 800 |
|
2015
Q4 | $1.33M | Hold |
145,236
| – | – | 0.01% | 742 |
|
2015
Q3 | $819K | Hold |
145,236
| – | – | 0.01% | 818 |
|
2015
Q2 | $1.61M | Hold |
145,236
| – | – | 0.02% | 660 |
|
2015
Q1 | $2.28M | Hold |
145,236
| – | – | 0.03% | 569 |
|
2014
Q4 | $2.21M | Buy |
+145,236
| New | +$2.21M | 0.03% | 563 |
|